A citation-based method for searching scientific literature

Daniela Adamo, Giuseppe Pecoraro, Noemi Coppola, Elena Calabria, Massimo Aria, Michele Mignogna. Oral Dis 2021
Times Cited: 4







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study.
Daniela Adamo, Giuseppe Pecoraro, Massimo Aria, Gianfranco Favia, Michele Davide Mignogna. Pain Med 2020
9
100

Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy.
Ana M Micov, Maja A Tomić, Marija B Todorović, Milja J Vuković, Uroš B Pecikoza, Nebojsa I Jasnic, Jelena D Djordjevic, Radica M Stepanović-Petrović. Prog Neuropsychopharmacol Biol Psychiatry 2020
5
75

Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain.
Anna Rita Zuena, Daniela Maftei, Giovanni Sebastiano Alemà, Francesca Dal Moro, Roberta Lattanzi, Paola Casolini, Ferdinando Nicoletti. Mol Pain 2018
12
75

Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis.
Chi-Un Pae, Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A Patkar, Praksh S Masand, Alessandro Serretti. J Psychiatr Res 2015
29
50

Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant.
Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, Rafał R Jaeschke, Katherine Sendek, Krzysztof Styczeń, Wojciech Datka, Magdalena Koperny. Pharmacol Rep 2017
30
50

Vortioxetine: a novel antidepressant for the treatment of major depressive disorder.
Xenia Gonda, Samata R Sharma, Frank I Tarazi. Expert Opin Drug Discov 2019
24
50

Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
Jean-Philippe Guilloux, Indira Mendez-David, Alan Pehrson, Bruno P Guiard, Christelle Repérant, Sophie Orvoën, Alain M Gardier, René Hen, Bjarke Ebert, Silke Miller,[...]. Neuropharmacology 2013
83
50

Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice.
Li-Xin Jiang, Geng-Di Huang, Feng Su, Huali Wang, Chen Zhang, Xin Yu. Psychopharmacology (Berl) 2020
6
50


Histamine may contribute to vortioxetine's procognitive effects; possibly through an orexigenic mechanism.
Gennady N Smagin, Dekun Song, David P Budac, Jessica A Waller, Yan Li, Alan L Pehrson, Connie Sánchez. Prog Neuropsychopharmacol Biol Psychiatry 2016
8
50

Vortioxetine: A new alternative for the treatment of major depressive disorder.
Estela Salagre, Iria Grande, Brisa Solé, Jose Sanchez-Moreno, Eduard Vieta. Rev Psiquiatr Salud Ment (Engl Ed) 2018
15
50




Drug interactions with vortioxetine, a new multimodal antidepressant.
Edoardo Spina, Vincenza Santoro. Riv Psichiatr 2015
8
50

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.
David S Baldwin, Lambros Chrones, Ioana Florea, Rebecca Nielsen, George G Nomikos, William Palo, Elin Reines. J Psychopharmacol 2016
59
50

Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004.
Mette G Hvenegaard, Benny Bang-Andersen, Henrik Pedersen, Morten Jørgensen, Ask Püschl, Lars Dalgaard. Drug Metab Dispos 2012
51
50

Neuropathic pain.
Luana Colloca, Taylor Ludman, Didier Bouhassira, Ralf Baron, Anthony H Dickenson, David Yarnitsky, Roy Freeman, Andrea Truini, Nadine Attal, Nanna B Finnerup,[...]. Nat Rev Dis Primers 2017
618
50

The association between burning mouth syndrome and sleep disturbance: A case-control multicentre study.
D Adamo, A Sardella, E Varoni, C Lajolo, M Biasotto, G Ottaviani, P Vescovi, T Simonazzi, M Pentenero, M Ardore,[...]. Oral Dis 2018
24
50

Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies.
Jacob Ablin, Mary-Ann Fitzcharles, Dan Buskila, Yoram Shir, Claudia Sommer, Winfried Häuser. Evid Based Complement Alternat Med 2013
73
25

An Association of Serotonin with Pain Disorders and Its Modulation by Estrogens.
Stephania Paredes, Santiago Cantillo, Kenneth D Candido, Nebojsa Nick Knezevic. Int J Mol Sci 2019
20
25

Dopaminergic neurotransmission and genetic variation in chronification of post-surgical pain.
Roel R I van Reij, Elbert A J Joosten, Nynke J van den Hoogen. Br J Anaesth 2019
6
25

Serotonin and Norepinephrine Reuptake Inhibitors.
Richard C Shelton. Handb Exp Pharmacol 2019
28
25

Prevalence of fibromyalgia: literature review update.
Amelia Pasqual Marques, Adriana de Sousa do Espírito Santo, Ana Assumpção Berssaneti, Luciana Akemi Matsutani, Susan Lee King Yuan. Rev Bras Reumatol Engl Ed 2017
61
25

Role of central dopamine in pain and analgesia.
Patrick B Wood. Expert Rev Neurother 2008
215
25

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.
Frederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, Don L Goldenberg, Robert S Katz, Philip Mease, Anthony S Russell, I Jon Russell, John B Winfield, Muhammad B Yunus. Arthritis Care Res (Hoboken) 2010
25

Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats.
Arantxa Blasco-Serra, Francesc Escrihuela-Vidal, Eva M González-Soler, Fernando Martínez-Expósito, M Carmen Blasco-Ausina, Sergio Martínez-Bellver, Ana Cervera-Ferri, Vicent Teruel-Martí, Alfonso A Valverde-Navarro. Physiol Behav 2015
25
25

Serotonin: a never-ending story.
Berend Olivier. Eur J Pharmacol 2015
126
25

Commentary: Evaluation of Models of Parkinson's Disease.
Pollyana C Leal, Lívia C R F Lins, Auderlan M de Gois, Murilo Marchioro, José R Santos. Front Neurosci 2016
10
25



The German fibromyalgia consumer reports - a cross-sectional survey.
Winfried Häuser, Eva Jung, Brigitte Erbslöh-Möller, Mechthild Gesmann, Hedi Kühn-Becker, Franz Petermann, Jost Langhorst, Reinhard Thoma, Thomas Weiss, Frederick Wolfe,[...]. BMC Musculoskelet Disord 2012
38
25

Ameliorative effect of imperatorin in chemically induced fibromyalgia: Role of NMDA/NFkB mediated downstream signaling.
Anudeep Kaur, Lovedeep Singh, Nirmal Singh, Manpreet S Bhatti, Rajbir Bhatti. Biochem Pharmacol 2019
18
25

Comparative effects of Rauwolfia vomitoria and chlorpromazine on locomotor behaviour and anxiety in mice.
Sunday Agba Bisong, Richard Brown, Eme Effiom Osim. J Ethnopharmacol 2010
18
25



Acute stress, depression, and anxiety symptoms among English and Spanish speaking children with recent trauma exposure.
Beth A Barber, Krista L Kohl, Nancy Kassam-Adams, Jeffrey I Gold. J Clin Psychol Med Settings 2014
8
25

Treatment of fibromyalgia: a changing of the guard.
Andrew J Holman. Womens Health (Lond) 2005
7
25

Fibromyalgia syndrome: Basic knowledge, diagnosis and treatment.
Winfried Häuser. Med Monatsschr Pharm 2016
4
25

Vortioxetine Reduces Marble Burying but Only Transiently Enhances Social Interaction Preference in Adult Male BTBR T+Itpr3tf/J Mice.
Nasriya A Witt, Benita Lee, Kaylee Ghent, Wynne Q Zhang, Alan L Pehrson, Connie Sánchez, Georgianna G Gould. ACS Chem Neurosci 2019
5
25

Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice.
Kinga Sałat, Katarzyna Gawlik, Jadwiga Witalis, Dorota Pawlica-Gosiewska, Barbara Filipek, Bogdan Solnica, Krzysztof Więckowski, Barbara Malawska. Naunyn Schmiedebergs Arch Pharmacol 2013
29
25

The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior.
Kathryn G Commons, Aram B Cholanians, Jessica A Babb, Daniel G Ehlinger. ACS Chem Neurosci 2017
186
25

Fibromyalgia patients show an abnormal dopamine response to pain.
Patrick B Wood, Petra Schweinhardt, Erik Jaeger, Alain Dagher, Helene Hakyemez, Eugenii A Rabiner, M Catherine Bushnell, Boris A Chizh. Eur J Neurosci 2007
253
25

Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.
K Fukuzaki, T Kamenosono, R Nagata. Pharmacol Biochem Behav 2000
34
25

Efficacy of vortioxetine in working patients with generalized anxiety disorder.
Michael Cronquist Christensen, Henrik Loft, Ioana Florea, Roger S McIntyre. CNS Spectr 2019
4
25

Pathophysiology of fibromyalgia.
Laurence A Bradley. Am J Med 2009
127
25

Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.
Heike Benes, Wolfgang Mattern, Ines Peglau, Tillmann Dreykluft, Lars Bergmann, Corinna Hansen, Ralf Kohnen, Norbert Banik, S W Schoen, Magdolna Hornyak. J Neurol 2011
38
25

Management of fibromyalgia syndrome in 2016.
Akiko Okifuji, Jeff Gao, Christina Bokat, Bradford D Hare. Pain Manag 2016
14
25

Anxiolytic profile of ropinirole in the rat, mouse and common marmoset.
D C Rogers, B Costall, A M Domeney, P A Gerrard, M Greener, M E Kelly, J J Hagan, A J Hunter. Psychopharmacology (Berl) 2000
44
25

The role of life stress in fibromyalgia.
Boudewijn Van Houdenhove, Ulrich Egle, Patrick Luyten. Curr Rheumatol Rep 2005
63
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.